HomeGDTC • NASDAQ
add
CytoMed Therapeutics Ltd
Previous close
$2.10
Day range
$2.08 - $2.11
Year range
$1.92 - $9.25
Market cap
24.32M USD
Avg Volume
7.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(SGD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 13.38K | -90.75% |
Operating expense | 1.03M | 49.02% |
Net income | -987.39K | 7.54% |
Net profit margin | -7.38K | -899.40% |
Earnings per share | — | — |
EBITDA | -921.21K | -105.48% |
Effective tax rate | -0.03% | — |
Balance Sheet
Total assets
Total liabilities
(SGD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.00M | 463.86% |
Total assets | 12.37M | 136.63% |
Total liabilities | 1.12M | -75.76% |
Total equity | 11.24M | — |
Shares outstanding | 11.54M | — |
Price to book | 2.16 | — |
Return on assets | -20.42% | — |
Return on capital | -21.60% | — |
Cash Flow
Net change in cash
(SGD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -987.39K | 7.54% |
Cash from operations | -699.56K | -53.14% |
Cash from investing | -1.41M | -5,388.64% |
Cash from financing | -257.00 | -100.05% |
Net change in cash | -2.11M | -4,652.40% |
Free cash flow | -576.45K | -100.47% |
About
Founded
2018
Website
Employees
28